Charlotte, NCNCT03555851Now EnrollingIRB Ready

Leukemia, Not Otherwise Specified Clinical Trial in Charlotte, NC

Access cutting-edge leukemia, not otherwise specified treatment through this clinical trial at a research site in Charlotte. Study-provided care at no cost to qualified participants.

Sponsored by Wake Forest University Health Sciences

Quick Self-Assessment

See if you qualify for this Charlotte location

Preparing your pre-screening questions…

Expert Care in Charlotte

Access leukemia, not otherwise specified specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related leukemia, not otherwise specified treatment provided free

Apply for This Charlotte Location

Check if you qualify for this leukemia, not otherwise specified clinical trial in Charlotte, NC

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Charlotte

    Convenient for NC residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Charlotte site if eligible
  4. 4Begin participation

About This Leukemia, Not Otherwise Specified Study in Charlotte

This study will examine the influence of donor and recipient pharmacogenetics (PG), drug pharmacokinetics (PK), and T cell phenotypes and how it may permit a tailored dosing strategy to improve the therapeutic index of post-transplant cyclophosphamide (PTCy) and optimize the graft versus tumor effect, while minimizing acute and chronic graft versus host disease (GVHD).

Sponsor: Wake Forest University Health Sciences

Who Can Participate

Inclusion Criteria

Recipients and donors must meet all of the following applicable inclusion criteria to participate in this study:
Informed consent and HIPAA authorization for release of personal health information signed by the subject.
Age ≥ 18 years at the time of consent.
Subject is scheduled as a recipient or respective donor (Donor consent/participation is not required for subjects undergoing matched unrelated donor HCT) for the following hematopoietic stem cell transplants (HCT) procedures using a non-myeloablative regimen at Levine Cancer Institute (LCI), and has been deemed a qualified candidate by his/her physician, per LCI medical standards: haplo-identical donor HCT, match related donor (MRD) HCT, matched unrelated donor (MUD) HCT.
Recipient only: Planned post-transplant cyclophosphamide
As determined by the enrolling physician, ability of the subject to understand and comply with study procedures for the entire length of the study

Exclusion Criteria

Subjects meeting any of the criteria below may not participate in the study:
Recipient only (applies only to haplo-identical and MRD HCT recipients; not required for MUD HCT recipients): Does not have a respective donor who is willing to sign informed consent for participation in this study.
Recipient only: Treatment with any investigational drug within 30 days prior to day -6 of treatment
Donor only (applies only to haplo-identical and MRD HCTs; donor participation is not required for MUD HCTs): Does not have a respective recipient who is willing to sign informed consent for participation in this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Charlotte?

Yes, this clinical trial (NCT03555851) has an active research site in Charlotte, NC that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Leukemia, Not Otherwise Specified Treatment Options in Charlotte, NC

If you're searching for leukemia, not otherwise specified treatment options in Charlotte, NC, this clinical trial (NCT03555851) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Charlotte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced leukemia, not otherwise specified specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all leukemia, not otherwise specified clinical trials near you to find additional studies recruiting in your area.

More Leukemia Trials in Charlotte, NC

See all leukemia clinical trials recruiting in Charlotte — not just this study.

Browse Leukemia Trials in Charlotte →

Browse More Trials by Condition

Leukemia TrialsHeart Attack TrialsPulmonary Embolism TrialsErectile Dysfunction TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Charlotte?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Charlotte, NC